YALA Q1 2026 Earnings EPS of 016 Highlights Solid Performance Amid Limited Disclosures RenovoRx Inc RNXT Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Holds Steady Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns SSC Technologies Q1 2026 Earnings EPS Slightly Beats Estimates Amid Operational Resilience ATNM Q1 2026 Earnings NarrowerthanExpected Loss Reflects Cost Discipline Amid IomabB Development Ascentage Pharma AAPG Advances 22 as Biotech Sector Finds Footing Western Asset Investment Grade Opportunity Trust IGI Holds Steady Near Key Support Resistance Ahead SPACSphere Acquisition Corp Rights SSACR Holds Steady Near Support as Thin Trading Continues SC II Acquisition Units SCIIU Hold Steady at 1018 as Trading Remains Muted WORX Q3 2025 Earnings EPS Loss of 015 Amid Significant Stock Surge